BE699207A - - Google Patents

Info

Publication number
BE699207A
BE699207A BE699207DA BE699207A BE 699207 A BE699207 A BE 699207A BE 699207D A BE699207D A BE 699207DA BE 699207 A BE699207 A BE 699207A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE699207A publication Critical patent/BE699207A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/12Sulfonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE699207D 1966-06-01 1967-05-30 BE699207A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0087382 1966-06-01

Publications (1)

Publication Number Publication Date
BE699207A true BE699207A (en) 1967-11-30

Family

ID=6983770

Family Applications (1)

Application Number Title Priority Date Filing Date
BE699207D BE699207A (en) 1966-06-01 1967-05-30

Country Status (5)

Country Link
AT (1) AT274466B (en)
BE (1) BE699207A (en)
CH (1) CH489193A (en)
DE (1) DE1542826B1 (en)
GB (1) GB1179907A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013274406B2 (en) * 2012-06-11 2017-02-02 The Cleveland Clinic Foundation Treatment and prevention of cardiovascular disease and thrombosis
EP3522927B1 (en) 2017-10-02 2020-11-25 The Procter and Gamble Company Methods for inhibiting conversion of choline to trimethylamine (tma)
WO2019070677A1 (en) 2017-10-02 2019-04-11 The Procter & Gamble Company Methods for inhibiting conversion of choline to trimethylamine (tma)
BR112020006108A2 (en) * 2017-10-02 2020-09-24 The Procter & Gamble Company methods to inhibit the conversion of choline to trimethylamine (tma)

Also Published As

Publication number Publication date
DE1542826B1 (en) 1971-04-08
GB1179907A (en) 1970-02-04
CH489193A (en) 1970-04-30
AT274466B (en) 1969-09-25

Similar Documents

Publication Publication Date Title
AT281852B (en)
AU5917865A (en)
AU428063B2 (en)
AU424443B2 (en)
AU433222B2 (en)
AU421822B2 (en)
AU417216B2 (en)
AU415165B1 (en)
AU414526B2 (en)
AU218666A (en)
AU6703465A (en)
AU5895065A (en)
AU612166A (en)
AU1144366A (en)
AU1111066A (en)
AU411645B2 (en)
BE624223A (en)
AU414093B2 (en)
AU433620A (en)
AU407778B2 (en)
BE618801A (en)
AU1027866A (en)
AU855865A (en)
BE707637A (en)
AU2390066A (en)